Results 161 to 170 of about 134,715 (210)

Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack. [PDF]

Stroke
Lin J, Zhou H, Wang Y, Jin A, Li S, Zhang L, Meng X, Xie X, Jing J, Jiang Y, Wang Y, Zhao X, Li H, Li Z, Wang Y, CHANCE-2 Investigators.   +15 more
europepmc   +1 more source

Genetic variants of <i>CYP2C19</i> and <i>CYP2C18</i> and their clinical implications in the Saudi population. [PDF]

J Taibah Univ Med Sci
Alkattan A, Alhajri A, Almutairi Y, Kandeel M, Al-Taher A.   +4 more
europepmc   +1 more source

Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis. [PDF]

Open Heart
Zheng L, Ren Z, Shi Y, Zou J, Hao C, Li Y, Sun L, Wang D, Liu H, Liang S, Zhu B, Li C.   +11 more
europepmc   +1 more source

Revisiting the Proton Pump Inhibitor-Clopidogrel Conundrum: Do PPIs Truly Worsen Cardiovascular Outcomes? [PDF]

JACC Asia
Bavishi C, Hirai T.
europepmc   +1 more source

Pharmacological Management of Thrombosis: Current State and Future Strategies. [PDF]

Int J Mol Sci
Mogielnicki A.
europepmc   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). [PDF]

Br J Clin Pharmacol
Dello Russo C, Frater I, Kuruvilla R, Lip S, O'Neill H, Burke K, Chaplin V, Doney ASF, Elyas S, Greaves N, Harding S, Hargroves D, Hayward J, Hughes DA, Hughes TAT, Kondapally S, Mok P, Peace A, Rafi I, Ray S, Stinton V, Venetucci L, Pirmohamed M.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clopidogrel

Drugs, 1997
Clopidogrel is a thienopyridine that irreversibly inhibits platelet aggregation by selectively binding to adenylate cyclase-coupled ADP receptors on the platelet surface. In animal models, clopidogrel reduced the formation of both arterial and venous thrombi.
A J, Coukell, A, Markham
openaire   +3 more sources

Clopidogrel Resistance

American Journal of Therapeutics, 2010
Clopidogrel resistance is an emerging clinical scenario, as antiplatelet therapy has become the cornerstone of modern cardiovascular treatment. This leads to an increase in stent thromboses and recurrent ischemic events which add to the health care costs, and increased periprocedural morbidity and mortality.
Jaya Prakash, Sugunaraj, Chandrasekar, Palaniswamy, Dhana Rekha, Selvaraj, Sri Krishna, Chaitanya Arudra, Rishi, Sukhija   +4 more
openaire   +2 more sources

Clopidogrel Resistance

Heart, Lung and Circulation, 2007
Clopidogrel resistance has been used as one of the terms employed in the literature to describe different degrees of ex vivo low platelet inhibition after clopidogrel administration. In addition to the diverse nomenclature, the characterisation of clopidogrel resistance has also been problematic because different authors have given different ...
Ernesto, Oqueli, Martin, Hiscock, Ronald, Dick   +2 more
openaire   +2 more sources

Clopidogrel “resistance”

Thrombosis and Haemostasis, 2004
Karsten, Schrör, Artur Aron, Weber, Thomas, Hohlfeld   +2 more
openaire   +4 more sources